Nir Barzilai, M.D. Director of the Institute for Aging

Research Director of the Nathan Shock Center of Excellence in the Basic Biology of Aging

Ingeborg and Ira Leon Rennert Chair of Aging Research

Dr. Barzilai's bio / cv

Watch video

Request an Interview with Dr. Barzilai

Watch Dr. Barzilai in The Healthspan Imperative

The Longevity Genes Project

What if people could live to be 100 and beyond and still be healthy, active and engaged?

What if there were a way to age without a slow and painful decline?

In the Longevity Genes Project at Albert Einstein College of Medicine, Dr. Nir Barzilai and his team conducted genetic research on more than 500 healthy elderly people between the ages of 95 and 112 and on their children.

The identification of longevity genes by Einstein researchers could lead to new drug therapies that might help people live longer, healthier lives and avoid or significantly delay age-related diseases such as Alzheimer's disease, type 2 diabetes and cardiovascular disease.

The Longevity Genes Project Video Series

This video series includes informative interviews with Dr. Nir Barzilai, who leads the Einstein longevity research efforts, and with four study participants whose diverse and compelling stories will inspire you. We invite you to view all of the videos and leave comments. Click on the links below to view each segment.

Research: Dr. Nir Barzilai

Personal Profiles: Lilly Port: Age 96 | Harold Laufman: Age 98 | Irma Daniel: Age 103 | Irving Kahn: Age 104

Longevity and Longenity Information and preliminary results of Einstein's search for longevity genes in the Jewish Ashkenazi population and genotypes and phenotypes for exceptional longevity.

Why Ashkenazi Jews? Information about the "founder effect" and the historically unique Ashkenazi Jewish population.

Read more:
Longevity Genes Project | Institute for Aging Research ...